(Accepted 28 April 1980) Adverse effect of plasma exchange on anti-D production in rhesus immunisation owing to removal of inhibitory factors G R BARCLAY, M AYOUB GREISS, S J URBANIAK Summary and conclusions Intensive plasma exchange was used to reduce the maternal anti-D concentration in a case of severe rhesus haemolytic disease. Initially the concentration fell from 30 to 4 IU/ml, but after six exchanges it increased to 490 IU/ml despite continued exchanges, and intrauterine fetal death eventually ensued. The increase in the rate of maternal anti-D production coincided with, and may have resulted from, removal of plasma immunoregulatory factors that inhibited in-vitro lymphocyte functions.
These results suggest that the role of plasma exchange in haemolytic disease of the newborn is more complex than simply removing the antibody and that further investigations are needed. and serum lymphocyte-regulating activity in a case of severe haemolytic disease of the newborn.
Methods
Plasma exchanges were carried out with a continuous-flow cell separator (Aminco Celltrifuge). During each exchange an average of 4 1 of maternal plasma was exchanged for an equal volume of normal donor fresh-frozen plasma. Maternal serum was obtained from clotted blood samples taken before and after each exchange: the serum anti-D concentration was measured by routine autoanalyser techniques,5 and serum for lymphocyte studies was decomplemented (56°C for 30 minutes) and stored at -40°C for retrospective investigations.
Antibody-dependent cell-mediated cytotoxicity was determined by using column-purified peripheral blood lymphocytes as effectors (K-cell activity) and Rh(D)-positive human red cells as targets (ratio of effector to target 10:1) in the presence of test anti-D sera as described. 6 The effects of sera on lymphocyte proliferative responses to mitogens were determined by modifications of previously described culture techniques.7 Lymphocytes were cultured at 02 x 109/l in 150 [1 volumes on round-bottom microculture plates (24-ARTL, Flow Labs) and stimulated by concanavalin A (x 3 recrystallised in ammonium sulphate, Miles Labs) at 16 mg/I. Cultures were supplemented with 20% decomplemented human serum:-control cultures contained pooled normal human serum alone, while test cultures contained a one to one mixture of pooled normal human serum to test serum (that is, 10% v/v respectively of final cultures). Responses were measured by the amount of tritiated thymidine incorporated into lymphocytes and results expressed as a percentage of the lymphocytes' response in the control culture (pooled normal human serum alone). The results shown were obtained by using matemal lymphocytes (from a sample obtained two months after intrauterine death) for the studies of antibody-dependent cell-mediated cytotoxicity and proliferation.
Case report-A 36-year-old group 0, Rh-negative (cde/cde) woman presented in the 27th week of gestation of her third pregnancy with detectable serum concentrations of anti-C+D. Her husband's blood group was B, R1R2 (CDe/cDE). She had developed anti-C+D during her second pregnancy, when the baby was Coombs positive and mildly jaundiced but required no postnatal treatment. At presentation her antibody concentrations were: antiglobulin titre anti-C 1/32 and anti-D 1/32. By autoanalyser her serum anti-D concentration was 23-2 IU/ml and anti-D in amniotic fluid 2 0 IU/ml, and intrauterine transfusion was carried out. By the 28th week of gestation the maternal anti-D concentration had reached 30 IU/ml, and plasma exchange was started (day 0; figure). Amniocentesis and intrauterine transfusion were repeated during the course of plasmaexchanges.
Results
Effect of plasma exchanges on maternal anti-D concentration-After six daily exchanges the maternal anti-D concentration had fallen from 30 to 4 IU/ml (figure). The rate of maternal production of anti-D, however, increased thereafter, and, despite continued exchanges, the concentration rose to a peak of 490 IU/ml at day 14 and remained substantially raised thereafter. Fetal death in utero was recorded on day 22.
Serum effects on antibody-dependent cell-mediated cytotoxicity of D-positive red cells-Observations have shown that the antibodydependent cell-mediated cytotoxicity of serum containing anti-D is proportional to the anti-D concentration, so that dilution reduces the "lytic potential."6 In the present case the opposite effect was observed (figure), since the anti-D lytic potential was greater after than before the exchanges, although the anti-D concentration had been reduced 
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Discussion
Contrary to our expectations, intensive plasma exchange did not successfully sustain a reduction in maternal concentrations of anti-D in this case of haemolytic disease of the newborn (figure). Although the anti-D concentration fell initially from 30 to under 5 IU/ml, it "escaped" control and rose to 490 IU/ml, and evidence suggests that this was a consequence of the plasmaexchange treatment. Inhibitory activity was present in the mother's serum before treatment, which affected lymphocyte transformation to concanavalin A and lymphocyte (K-cell) antibody-dependent cell-mediated cytotoxicity against Rh(D)-positive red blood cells. Removing this inhibitory activity during the course of plasma exchange appeared to result in (i) an increase in the antibody-dependent cell-mediated cytotoxicity lytic potential of the patient's anti-D despite a reduction in the anti-D concentration and (ii) an increase in the rate of maternal anti-D production.
The clinical consequences of increased K-cell activity in haemolytic disease of the newborn have yet to be established. Antibody-dependent cell-mediated cytotoxicity by fetal lymphocytes may contribute to red-cell lysis in utero8; whether maternal plasma regulators cross the placenta to influence fetal lymphocyte function is not known.
An increased maternal anti-D response represents a direct threat to fetal survival. In this case the evidence suggests that removing a plasma inhibitor of lymphocyte activities allowed the rate of anti-D production to increase. Whether Although plasma exchange has been used with moderate success' 2 to reduce anti-D concentrations in haemolytic disease of the newborn, in such cases (and in other diseases caused or complicated by harmful antibodies) immune regulatory responses may possibly be disturbed by plasma exchange.9 10 Isbister et a19 reported the development of autoantibodies with Rh-complex specificity in two mothers in whom plasma exchange was used to treat anti-D haemolytic disease of the newborn and cautiontd against removing "feedback inhibition" mechanisms for controlling antibody production during plasma exchange. In animal studies plasma exchange during a primary response tends to enhance the rate of antibody production, while during a secondary response it can reduce and maintain low antibody concentrations'0: the clinical implications of this are that plasma exchange should be more effective in achieving low antibody concentrations during secondary anamnestic responses than during primary responses; this is, however, contrary to our experience in the present case, where the influence of continued antigenic stimuli may Whether the inhibitory activity is produced by the mother as part of a "feedback" control mechanism or by the fetus as a protective mechanism against the effects of the anti-D is not known. Our preliminary observations on the serum of cordblood-mother pairs indicate that in general cord-blood sera are inhibitory while the corresponding maternal sera are not, suggesting that the fetus may produce its own inhibitory activity. In the present case, however, the inhibitory activity was more probably of maternal origin since six exchanges (total of 24 litres) were required to remove it. We have recently undertaken plasma exchanges on several other women sensitised to anti-D with disappointing results, despite using a more intensive regimen than that reported to be successful elsewhere.2 Our present findings suggest that the role of plasma exchange in haemolytic disease of the newborn is more complex than simply removing the antibody and that further investigations are required.
Introduction
Many techniques are used for detecting leg-vein thrombosis.' Ascending venography is the yardstick by which all others are measured but it is often uncomfortable and carries a small but definite morbidity.2 The use of fibrinogen labelled with iodine-125 avoids the problem of discomfort and has the major advantage of being performed at the bedside. It has two major disadvantages, however. Firstly, though accuracy is good in detecting calf-vein thrombosis it diminishes in the thigh,1 and the method is useless for detecting pelvic-vein thrombosis; secondly, its value lies in detecting thrombi as they form, whereas it does not accurately identify already established thrombi.
Platelets labelled with indium-11l have been used to estimate platelet survival,4-7 to diagnose renal transplant rejection,8 and in attempts to detect atherosclerotic plaques. 9 10 This study was undertaken to determine whether platelets labelled with this radionuclide were useful in detecting established venous thrombosis.
Materials and methods
Platelets were labelled with indium-ill by the method of Hawker et al.6 711 A total of 26 ml of venous blood was withdrawn with an 18-gauge needle, 9 ml being added to 1 ml 3-8% trisodium citrate and used for aggregation standards and the production of platelet-poor plasma. The remaining 17 ml was anticoagulated with 3 ml acid citrate and the platelets separated by differential centrifugation, washed, resuspended in Ca++-free Tyrode's solution containing prostaglandin E1 (Imperial Chemical Industries Ltd), and incubated with 200-250 pCi indium-ill oxine (Radiochemical Centre) at 37°C for 60 seconds. After centrifugation the platelets were suspended in 5 ml of platelet-poor plasma and reinjected into the patient 45-60 minutes after the initial venepuncture. Scanning at slow speed was performed with an El-Scint wholebody scanner fitted with medium-energy VC-3 collimators, and the data were displayed on a VD2 videoprocessing colour display. Regions of interest were imaged with an Ohio Nuclear series 410 wide-fieldof-view gammacamera linked to a Digital Equipment Corporation Gamma-1 computer system.
Ascending venography was performed on all patients after scanning was completed and the findings reported without knowledge of the results of scanning.
Results
Eight patients were studied. Ascending venography was performed on 13 legs, and five thrombi were identified in four. The number, location, and extent of these correlated precisely with the areas in
